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Leptin is a negative acute phase protein in chronic hemodialysis predictor of morbidity and mortality in this population
patients. [1–3]. Depending on the parameter measured, the preva-
Background. Hypoalbuminemia strongly predicts death in lence of malnutrition in the chronic dialysis populationhemodialysis patients and results from both inflammation and
ranges from 10 to 54% [4–8]. This has been substantiatedmalnutrition. One potential link between malnutrition and in-
by a growing body of evidence linking poor nutritionalflammation is appetite suppression triggered by inflammation.
Leptin is secreted by adipose tissue and suppresses appetite, status in the dialysis population with increased morbidity
and it is also a positive acute phase protein in the rat. Factored and mortality. Clinicians, using hypoalbuminemia as
for body weight, leptin is known to be increased in hemodialysis
their principal nutritional marker, have recognized forpatients, but its relationship to inflammation is unknown.
many years that their malnourished dialysis patients hadMethods. We examined the relationship between spontane-
ously occurring activation of the acute phase response and a poorer prognosis, and serum albumin appeared to be
leptin levels in 29 chronic hemodialysis patients. Serum samples the most significant marker of mortality in patients with
were obtained three times weekly for six weeks and then renal failure [9].monthly from 29 chronic hemodialysis patients, and the levels
Recently, it has been recognized that a substantialof the positive acute phase proteins [C-reactive protein (CRP),
number of patients with end-stage renal disease havea1-acid glycoprotein (a1 AG), serum amyloid A, ceruloplas-
min] and the negative acute phase proteins (albumin and trans- serologic evidence of an activated inflammatory state
ferrin) as well as leptin and interleukin-6 (IL-6) were measured. [10]. Moreover, evidence of inflammation may be as im-
Results. Positive and negative acute phase proteins were
portant or more important than protein intake in causingevaluated at the maximum CRP (mean, 9.42 6 1.14 mg/dL)
hypoalbuminemia [11]. It has long been known that albu-and minimum values (mean, 0.41 6 0.09 mg/dL). When CRP
was elevated, leptin levels were significantly reduced, as were min synthesis is effectively and rapidly reduced during
the negative acute phase proteins albumin and transferrin. Se- inflammation leading to hypoalbuminemia [12]. In addi-
rum amyloid A, ceruloplasmin, a1 acid glycoprotein, and IL-6 tion, clinical wasting is not the unique province of malnu-were all significantly increased at the maximum CRP level,
trition. This is illustrated by the fact that consumptioncompatible with general activation of the acute phase response.
was the term applied in the last century to patients withThe change in leptin correlated negatively with the change in
CRP (R 5 0.437, P 5 0.018), as did changes in albumin (R 5 tuberculosis, which is the clinical prototype of chronic
0.620, P , 0.001). inflammation. As we better understand the association
Conclusions. Leptin is not increased as a consequence of
between patient outcomes and nutritional status, whatinflammation in hemodialysis patients, but behaves as a nega-
is emerging is an understanding that there is an interplay,tive rather than as a positive acute phase protein. Inflammation
is unlikely to reduce appetite in dialysis patients through a interdependence, and interaction between caloric and
leptin-mediated mechanism. protein intake and the inflammatory state in patients
with chronic renal failure; together, they contribute to
Protein and calorie (energy) malnutrition is common both a wasting syndrome and increased morbidity and
in patients with end-stage renal disease and is a powerful mortality.
One potential relationship between malnutrition and
inflammation in patients with end-stage renal diseaseKey words: inflammation, albumin, C-reactive protein, cytokines, in-
terleukin-6, ceruloplasmin, a1-acid glycoprotein. is appetite suppression triggered by the inflammatory
response [13]. The link between inflammation and an-
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meostatic role in maintaining body composition [14]. In of these values was used for calculations. Serum amyloid
A concentrations were measured by ELISA using a kitaddition, leptin functions as a positive acute phase pro-
tein in experimental animals, being positively regulated obtained from Hemagen (Hemagen Diagnostics Incor-
porated, Waltham, MA, USA), serum IL-6 levels byat the mRNA level by the cytokines, tumor necrosis
factor-a (TNF-a) and interleukin-1 (IL-1) [15–17]. Since ELISA (R&D Systems, Minneapolis, MN, USA), and
serum leptin concentrations by ELISA DSL (Diagnosticsserum leptin levels are markedly increased in patients
with chronic renal failure [18, 19], activation of the in- Systems Laboratories Inc., Webster, TX, USA).
flammatory response in this patient population may be
Statistical analysisresponsible, in part, for increased leptin levels.
We recently noted that the levels of acute phase pro- Differences between serum concentrations of each of
the proteins measured coinciding with the peak andteins may vary by orders of magnitude in a single patient
over short time periods [20]. These large changes pro- trough value for CRP were analyzed by Student t test
for paired data for normally distributed data and byvided the opportunity to establish whether there was a
relationship between spontaneously occurring activation Wilcoxon signed rank test for non-normally distributed
data. The difference between the peak and trough valueof the acute phase response and changes in serum leptin
levels in dialysis patients. for CRP (DCRP) was calculated, as was the difference
between the value for each of the other proteins of inter-
est coinciding with those values of CRP. These differ-
METHODS
ences were then the D for each protein that corresponded
Patient selection with the difference in CRP values (DCRP). The correla-
tion between the change in the concentration of eachPatients at the University of California Davis Medical
Center (Sacramento, CA, USA), Beth Israel Medical protein with the changes in CRP (DCRP) was analyzed
by linear regression.Center (New York, NY, USA), and Emory University
Medical Center (Atlanta, GA, USA) were recruited to
participate in an ancillary longitudinal study of the rela-
RESULTS
tionship of the levels of acute phase proteins to serum
The age range for the 29 patients participating in thisalbumin concentration. The study was approved by the
study was 19 to 75 years, with a median age of 60 years.Institutional Review Boards at each institution.
Nineteen patients were men. Twelve patients had diabe-During the first six weeks of observations, predialysis
tes mellitus, and 16 patients were African American. Theblood samples were obtained weekly. Following that pe-
body mass index ranged from 15.94 to 32.61 kg/m2, withriod, each protein was measured monthly on serum ob-
a median value of 23.31 kg/m2.tained from predialysis samples. The sampling period
The average number of episodes in which the CRPranged from 7 to 28 months (median 18.5 months). Sam-
level was greater than 1.0 mg/dL was 9.4 6 1.2 per patientples having the maximum and minimum C-reactive pro-
per year. The mean maximum CRP concentration fortein (CRP) levels in blood previously obtained from 29
the group was 9.42 6 1.14 mg/dL, and the minimumconsecutive patients with end-stage renal disease on
concentration was 0.41 6 0.09 mg/dL. These were sig-chronic hemodialysis were chosen for measurement of
nificantly different by experimental design (P , 0.0001).leptin and both negative (albumin, transferrin) and posi-
The positive acute phase proteins, serum amyloid A (Fig.tive [serum amyloid A (SAA), a1-acid glycoprotein (a1
1A) and the cytokine IL-6 (Fig. 1B) were also signifi-AG), ceruloplasmin) acute phase proteins and one of the
cantly greater during the period when CRP was maximal.cytokines that regulates them (IL-6)]. The time interval
Similarly, the minor acute phase proteins, ceruloplasminbetween maximum and minimum CRP levels varied
(Fig. 2A) and a1 AG (Fig. 2B), were also significantlyfrom 7 to 392 days (median 147 days). The body mass
greater during the period when CRP was maximal. Byindex (kg/m2) was calculated for each patient using the
contrast, leptin decreased significantly (Fig. 3A), as didheight and weight obtained the day that the maximum
the concentrations of the known negative acute phaseand minimum CRP values were noted.
proteins albumin (Fig. 3B) and transferrin (Fig. 3C) dur-
Laboratory methods ing the period when CRP was maximal.
There was a positive correlation between the changesSerum albumin was measured in duplicate using bro-
in CRP at maximum and minimum concentrationsmocresol green. Serum transferrin, CRP, a1-acid glyco-
(DCRP) and changes in SAA at the same time pointsprotein, and ceruloplasmin were each measured with
(DSAA; Fig. 4A). A similar positive correlation was ob-rate nephelometry using a Beckman Array automated
served between the changes in CRP at maximum andnephelometer (Beckman Instruments, Fullerton, CA,
minimum levels and the changes in ceruloplasmin (Fig.USA) [21]. All nephelometric measurements were made
in duplicate in each of two optical systems. The average 4B), a1 AG (Fig. 4C), and IL-6 (Fig. 5). In contrast,
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Fig. 1. Serum amyloid A (SAA; A) and in-
terleukin-6 (IL-6; B) levels at minimum and
maximum levels of C-reactive protein (CRP).
Both SAA and IL-6 increased significantly
when CRP increased as analyzed by Wilcoxon
signed rank test.
Fig. 2. Ceruloplasmin (A) and a1-acid glyco-
protein (a1 AG) (B) levels at minimum and
maximum levels of CRP. Both ceruloplasmin
and a1 AG increased significantly when CRP
increased as analyzed by paired t test.
Fig. 3. Leptin (A), albumin (B), and trans-
ferrin (C ) at minimum and maximum levels
of CRP. All three proteins decreased signifi-
cantly when CRP increased as analyzed by
Wilcoxon signed rank test (leptin) and paired
t test (albumin and transferrin).
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Fig. 4. Regression analysis comparing the
changes in CRP levels (DCRP) with changes
in serum amyloid A (DSAA; mg/mL; A), ceru-
loplasmin (mg/dL; B) and a1-acid glycopro-
tein (a1 AG; mg/dL; C ). There is a significant
positive correlation between changes in CRP
levels and these three positive acute phase
proteins.
animal [22], investigators have sought to link the an-
orexia and wasting associated with several chronic ill-
nesses, including chronic renal failure, to abnormalities
in leptin metabolism. Serum leptin levels are markedly
elevated in patients with chronic renal failure compared
with healthy adults matched for gender and body mass
index [18, 23, 24]. From these studies, a number of obser-
vations have been made regarding leptin metabolism in
patients with chronic renal failure. First, there is an in-
verse correlation between leptin levels and glomerular
filtration rate in patients with chronic renal insufficiency
[25, 26]. Furthermore, the ratio of leptin to total fat is
significantly greater in renal failure patients compared
with normal control subjects [19]. A major cause of the
elevated leptin levels in renal failure is reduced renal
clearance [24, 27], but other factors such as hyperinsulin-
emia [28] and inflammation [29] have been implicated
Fig. 5. Regression analysis comparing the changes in IL-6 (pg/mL) in augmenting leptin secretion in renal failure.with changes in CRP levels (mg/dL). There is a significant positive
Experimental and clinical studies have demonstratedcorrelation between changes in IL-6 with changes in CRP (r 5 0.509;
P , 0.005). that inflammatory cytokines can stimulate leptin synthe-
sis and secretion. The administration of TNF-a, IL-1 or
endotoxin in experimental animals produces a prompt
increase in serum leptin levels and leptin mRNA expres-there was a negative correlation between the changes in
sion in adipose tissue [15, 17]. In cancer patients, infusionCRP and changes in leptin, albumin, and transferrin (Fig.
of either interleukin 1a [30] or TNF-a [31] has been6 A–C, respectively).
shown to increase serum leptin levels, and in controlThere was no significance difference in body mass
subjects and patients with type 2 diabetes mellitus, theindex between the periods of high and low CRP levels
levels of soluble TNF-a receptor (a sensitive indicator(24.37 6 1.26 vs. 24.35 6 1.33 kg/m2). There was also no
of TNF-a activity) are correlated with leptin levels [32].effect of the time interval between when the samples
Thus, these observations suggest that the anorexia seenwere drawn and the change in leptin levels.
in both acute and chronic inflammatory diseases may be
due to increased leptin synthesis and secretion.
DISCUSSION During the last 10 years, several investigators have
shown that a significant percentage of chronic hemodial-Since the discovery of leptin in 1994 as an important
factor influencing appetite and energy expenditure in ysis and peritoneal dialysis patients have increased levels
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Fig. 6. Regression analysis comparing the
changes in CRP levels (DCRP; mg/dL) with
changes in leptin (ng/mL; A), albumin (g/dL;
B), and transferrin (mg/dL; C). There is a sig-
nificant negative correlation between changes
in CRP levels and changes in these three pro-
teins.
of inflammatory mediators, including IL-1, IL-6, and and changes in CRP levels at maximum and minimum
values. In short, leptin responds like a negative acuteTNF-a, suggesting that the systemic inflammatory re-
sponse is an important part of the clinical physiology phase protein, rather than a positive acute phase protein
in the presence of inflammation.of chronic dialysis patients [10, 33, 34]. The emerging
concept is that many patients with chronic renal failure A review of the literature reveals conflicting conclu-
sions regarding the effect of inflammation on leptin. Infu-have chronic intermittent activation of the systemic
inflammatory response [35]. This leads to a complex com- sion of cytokines has been shown to augment leptin levels
in experimental animals and in patients. In a cross-sec-bination of physiologic, immunologic, and metabolic ef-
fects, termed the acute phase response. IL-1 and TNF-a tional study of chronic peritoneal dialysis patients,
Heimburger et al noted a positive correlation betweenstimulate the production of the positive acute phase pro-
teins, which include CRP, SAA, ferritin, haptoglobin, serum leptin concentration and serum TNF-a levels [40].
The latter report emphasizes the limits of cross-sectionalcomplement 3 and a1 AG [36]. Cytokines can also inhibit
the synthesis of proteins (negative acute phase proteins), studies. In contrast, Landt et al [41] and Parry et al [42]
failed to find any correlation between serum leptin levelsincluding albumin and transferrin. That serum albumin
is a negative acute phase protein supports the contention and CRP in peritoneal dialysis patients. In a study by
Norfors et al, the expression of mRNA for the leptinthat hypoalbuminemia is actually a marker of inflamma-
tion rather than malnutrition. In fact, Bergstro¨m et al gene was greater in chronic renal failure patients with
CRP levels more than 25 mg/dL [25]; however, serumnoted that CRP was a more powerful predictor of mortal-
ity for hemodialysis patients than hypoalbuminemia (ab- leptin levels were not significantly increased. Finally, in
a crossover study design examining dialyzer membranestract; J Am Soc Nephrol 6:573A, 1995). This observation
has been confirmed by Zimmerman et al [37] and Yeun biocompatibility, Coyne et al found no correlation be-
tween leptin and TNF-a levels in eight chronic hemodial-et al [38], and the relationship holds for IL-6 [39].
Based on our longitudinal observation that chronic ysis patients [43]. In other chronic inflammatory condi-
tions such as inflammatory bowel disease [44], therehemodialysis patients have intermittent activation of the
acute phase response [20] and the experimental data appears to be no relationship between disease activity
and leptin levels, thus confirming the observation thatsuggesting that inflammatory cytokines stimulate leptin
synthesis and secretion, we measured serum leptin levels unlike exogenous administration of cytokines, endoge-
nous inflammation does not appear to be associated withat maximum and minimum points of activation of the
acute phase response, as assessed by serum CRP levels. stimulation of leptin secretion. Indeed, changes in serum
leptin levels in patients with inflammatory bowel diseaseSerum leptin levels were significantly lower when CRP
levels were at maximum levels. The pattern of the leptin can be explained by changes in body mass index rather
than disease activity [45].levels noted at the peak and nadir of CRP levels was
similar to that observed with the negative acute phase What other factors could explain why activation of
the acute phase response is associated with a reductionproteins, albumin and transferrin. In addition, there was
also a negative correlation between the changes in leptin in leptin levels? One possibility is insulin-like growth
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research service of the United States Department of Veterans Affairs,factor (IGF-1), since malnutrition and inflammation are
in part by a grant from Dialysis Clinics Incorporated, and in part byboth associated with low levels of IGF-1 and administra- the Renal Research Institute.
tion of IGF-1 will increase serum leptin levels in chronic
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